Showing results (91-100 of 223) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|November 25, 2004
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Cécile Dalban, Gilles Peytavin, et al.
Blood Transfusion = Trasfusione Del Sangue|February 17, 2022
Hepatitis E infection in adults with primary immunodeficiency with or without immunoglobulin replacement therapyLaurence Gérard, Margaux Garzaro, Venicia Ferrer, et al.
Antiviral Therapy|August 20, 2003
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial)Constance Delaugerre, Karine Gourlain, Roland Tubiana, et al.
Antiviral Therapy|July 21, 2004
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmissionConstance Delaugerre, Laurence Morand-Joubert, Marie-Laure Chaix, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2015
Virological failure of patients on maraviroc-based antiretroviral therapyStéphanie Raymond, Anne Maillard, Corinne Amiel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2010
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assaysJean-Marie Sire, Muriel Vray, Mourad Merzouk, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapyMarc Wirden, Constance Delaugerre, Anne Genevieve Marcelin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2013
Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virusSarah Maylin, Anders Boyd, Michelle Martinot-Peignoux, et al.
Open Forum Infectious Diseases|April 2, 2021
Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY)Sylvain Chawki, Isabelle Charreau, Audrey Gabassi, et al.
AIDS (London, England)|October 17, 2018
Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphomaHéloïse M Delagreverie, Laurence Gerard, Antoine Chaillon, et al.
Pageof 23